Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 52 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 12 Carcinoma, Non-Small-Cell Lung 8 Neoplasms 4 Lung Neoplasms 4 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Blood Specimen Collection 7 Drug Therapy 6 Surveys and Questionnaires 5 Radiotherapy 5 Radiosurgery 5 Docetaxel 5 Therapeutics 4 Specimen Handling 4 Immunotherapy 4 Hepatectomy 4 exemestane 3 enzalutamide 3 apalutamide 3 Trastuzumab 3 Hematologic Tests 3 Data Collection 3 Biopsy 3 Biological Assay 3 Anastrozole 3 Abiraterone Acetate 3 trastuzumab deruxtecan 2 palbociclib 2 darolutamide 2 abiraterone 2 abemaciclib 2 Wearable Electronic Devices 2 Triptorelin Pamoate 2 Tamoxifen 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm Metastasis × Ipilimumab × Clear all

NCT03453892 2023-02-16

ST-ICI

University of Erlangen-Nürnberg Medical School

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡